CATALYSTYahoo Finance • 23h ago
iTonic Holdings Ltd Regains Compliance with Nasdaq Minimum Bid Price RequirementYahoo Finance report covering iTonic Holdings Ltd (Class A) (ITOC) market action, institutional positioning, and fundamental catalysts.
Why ITOC Stock dropped -9.61% Today — RQD Quant Desk Flash
$2.35 -9.61% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $2.30
iTonic Holdings Ltd (Class A) (ITOC) carries a Roarable Rating of E (Strong Sell) with 33/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE E • RED ALERT
Cap $19.0M
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER
Click Any Pre-Computed AI Quant Specialist Briefing on ITOC Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is ITOC stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-03, iTonic Holdings Ltd (Class A) (NASDAQ: ITOC) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 33/100 at a spot price of $2.35 (-9.61% 1D, market cap $19.0M). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 3/20, SEC Balance-Sheet Forensics 14/20, FRED Macro Regime Fit 5/20, and Executive Insider Alignment 3/20. Across 1015 tracked Health Care issuers, ITOC ranks #696 in composite RQD confidence.
✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does ITOC compare to IRIX and QTI in the Health Care sector?
▼
Within the Health Care sector (Biotechnology: Electromedical & Electrotherapeutic Apparatus), ITOC carries a Roarable E (33/100 RQD), trailing P/E of N/A, gross margin of 62.6%, and ROIC of -35.0%. By comparison, IRIX (IRIDEX Corporation) holds a E grade (27/100 RQD, P/E N/A, ROIC -35.0%, cap $12.5M) and QTI (QT Imaging Holdings Inc.) posts a E grade (29/100 RQD, P/E N/A, ROIC -35.0%, cap $31.3M). Among the 5-stock peer group, ITOC leads on earnings multiple (N/A) while ITOC leads on capital efficiency (-35.0% ROIC).
✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for ITOC?
▼
Per ITOC's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001970544), iTonic Holdings Ltd (Class A) generated $523.0K in revenue (+16.7% YoY), -$5.1M in net income, and -$3.2M in free cash flow against $9.1M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.
✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $2.30 (-1.92%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 8/20 (D-) • 0% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record Warning: Scores below 50 (33/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-8.9% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERRED ALERT • E
2-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw E · Rk D
Each axis scored 0–20
12M PRICE TARGET CONE-11.1% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for ITOC)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (33/100 Composite)
🔍 WHY ITOC SCORES 33/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+14/20 pts (42% of score)
Altman Z-Score 10.69 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 4/9
▲ #2 Bullish Driver: Cash Engine Quality+8/20 pts (24% of score)
SEC XBRL FY 2025 (10-K): 0% FCF Margin ($0 FCF) & 32.7% Gross Margin
▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)
Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade D$3.94-15% Next Q
41
Q2 (-2Q)Grade E$3.35-20.9% Next Q
38
Q3 (-1Q)Grade E$2.65-11.3% Next Q
36
CurrentGrade E$2.35-8.9% Hist 90D α
33
Trajectory: D (41) → E (33)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a ITOC Turnaround Squeeze
While ITOC currently carries a cautious 33/100 (E) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Established market leader in Health Care with deep daily trading liquidity.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($4.18) and Max Pain ($2.47) forces dealer call-delta covering toward $19.32.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $ITOC• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “ITOC Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why ITOC Stock dropped -9.61% Today — RQD Quant Desk Flash
iTonic Holdings Ltd (Class A) (ITOC) dropped -9.61% to $2.35, trading at 2% of its 52-week range ($2.12 – $18.4). Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 2% of its 52-week range ($2.12 – $18.4) with RSI-14 at 35.2 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $2.35 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable E (Strong Sell) backed by 32.7% gross margin and $0 annual free cash flow.
Live ITOC Headlines & Catalysts
MARKET WIRETradingView • 1d ago
iTonic Holdings Ltd Estimates – NASDAQ:ITOCTradingView report covering iTonic Holdings Ltd (Class A) (ITOC) market action, institutional positioning, and fundamental catalysts.
MARKET WIREMoomoo • 1d ago
ITonic To Carry Out 1-for-16 Reverse Stock Split On October 6th, 2026Moomoo report covering iTonic Holdings Ltd (Class A) (ITOC) market action, institutional positioning, and fundamental catalysts.
MARKET WIREBenzinga • 1d ago
12 Health Care Stocks Moving In Monday's After-Market Session - Biomea Fusion (NASDAQ:BMEA), iTonic HoldiBenzinga report covering iTonic Holdings Ltd (Class A) (ITOC) market action, institutional positioning, and fundamental catalysts.
MARKET WIREkalkine.ca • 1d ago
Why Is iTonic Holdings (NASDAQ:ITOC) Trading Near USD 3.00 After a 7.14% Rebound?kalkine.ca report covering iTonic Holdings Ltd (Class A) (ITOC) market action, institutional positioning, and fundamental catalysts.
MARKET WIRETraders Union • 1d ago
iTonic Holdings Ltd. (ITOC) Stock Price Prediction for 2026, 2030-2040Traders Union report covering iTonic Holdings Ltd (Class A) (ITOC) market action, institutional positioning, and fundamental catalysts.
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring ITOC)
- ✓Walkthrough of ITOC's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
ITOC // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -58.19%⚡ TESTING RESISTANCE
2026-11-03O $2.85H $2.85L $2.35C $2.35VOL 39.7K
RES: $2.96SUP: $2.08SMA50: $4.18SMA200: $5.11
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
ITOC Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle
8.0%/yr Implied 5Y Growth
vs. +16.7% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger
No active Ellis Vennor swing setup published on ITOC today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for ITOC. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for ITOC today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (ITOC)
Health Care Rank #696 of 1015
⚔️ IRIX vs ITOC Full Matrix →
1. Head-to-Head Health Care Peer Comparison (ITOC vs. IRIX, QTI, NDRA, POCI)
Industry: Biotechnology: Electromedical & Electrotherapeutic Apparatus (26 Tracked Issuers)Across 1015 tracked Health Care securities in the Roarable RQD universe, iTonic Holdings Ltd (Class A) (ITOC) ranks #696 by composite RQD confidence (33/100, grade E) and #832 by equity capitalization ($19.0M). Within this direct 5-issuer industry benchmark cohort, ITOC leads on earnings valuation at N/A trailing P/E, while ITOC leads on capital efficiency and profitability with -35.0% ROIC and 62.6% gross margin. NDRA currently holds the highest overall quantitative score in the immediate peer group at 36/100 (D-) compared with ITOC at 33/100 (E).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| ITOC
ACTIVE
iTonic Holdings Ltd (Class A) | E | 33/100 | — | 62.6% | -35.0% | -9.61% | $19.0M | Benchmark Subject |
| IRIX IRIDEX Corporation | E | 27/100 | — | 36.5% | -35.0% | +1.33% | $12.5M | /irix-vs-itoc → |
| QTI QT Imaging Holdings Inc. | E | 29/100 | — | 45.4% | -35.0% | +0.47% | $31.3M | /qti-vs-itoc → |
| NDRA ENDRA Life Sciences Inc. | D- | 36/100 | — | — | -35.0% | +1.05% | $7.1M | /ndra-vs-itoc → |
| POCI Precision Optics Corporation Inc. | E | 31/100 | — | 17.8% | -35.0% | +3.23% | $51.1M | /poci-vs-itoc → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001970544 ↗In its most recent audited fiscal period (FY2025, filed 2025-12-31), iTonic Holdings Ltd (Class A) (ITOC) reported GAAP revenue of $523.0K (+16.7% vs. FY2024 revenue of $448.2K , and -16.8% cumulative change since FY2023) , GAAP net income of -$5.1M, operating cash flow of -$3.2M, and free cash flow of -$3.2M (-317.0% YoY). On the balance sheet, ITOC closed FY2025 with $9.1M in total assets against $0 in total debt (Altman Z-Score: 10.69, Piotroski F-Score: 4/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $523.0K | -$5.1M | -$3.2M | -$3.2M | $9.1M | — |
| FY2024 (FY) | 2024-12-31 | $448.2K | -$660.6K | -$775.0K | -$775.9K | $6.7M | — |
| FY2023 (FY) | 2023-12-31 | $628.6K | -$241.2K | -$63.6K | -$63.6K | — | — |
3. ITOC Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs ITOC stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-03, iTonic Holdings Ltd (Class A) (NASDAQ: ITOC) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 33/100 at a spot price of $2.35 (-9.61% 1D, market cap $19.0M). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 3/20, SEC Balance-Sheet Forensics 14/20, FRED Macro Regime Fit 5/20, and Executive Insider Alignment 3/20. Across 1015 tracked Health Care issuers, ITOC ranks #696 in composite RQD confidence.
How does ITOC compare to IRIX and QTI in the Health Care sector?
Within the Health Care sector (Biotechnology: Electromedical & Electrotherapeutic Apparatus), ITOC carries a Roarable E (33/100 RQD), trailing P/E of N/A, gross margin of 62.6%, and ROIC of -35.0%. By comparison, IRIX (IRIDEX Corporation) holds a E grade (27/100 RQD, P/E N/A, ROIC -35.0%, cap $12.5M) and QTI (QT Imaging Holdings Inc.) posts a E grade (29/100 RQD, P/E N/A, ROIC -35.0%, cap $31.3M). Among the 5-stock peer group, ITOC leads on earnings multiple (N/A) while ITOC leads on capital efficiency (-35.0% ROIC).
What are the biggest fundamental strengths and SEC risk factors for ITOC?
Per ITOC's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001970544), iTonic Holdings Ltd (Class A) generated $523.0K in revenue (+16.7% YoY), -$5.1M in net income, and -$3.2M in free cash flow against $9.1M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.
Where is ITOC trading relative to its 50-day, 200-day, and 52-week technical levels?
ITOC last traded at $2.35 (-9.61% on volume of 31,190 shares), positioning the stock -43.78% below its 50-day simple moving average ($4.18) and -54.01% below its 200-day simple moving average ($5.11). Across its 52-week range of $2.12 to $18.40, ITOC sits at the 1.4% percentile with a 14-day RSI of 35.2 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($2.06 to $2.64).
ROARABLE RATING BRIEF • RQD 33/100 (E)
✓ SEC XBRL & RQD VERIFIED
ITOC — iTonic Holdings Ltd (Class A): What the Facts Mean to a Prospective Investor
Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-12-31
1. Roarable Rating Brief: What This Means to a Prospective Investor
iTonic Holdings Ltd (Class A) (ITOC) earns a live Roarable RQD composite score of 33/100, corresponding to a E letter grade (Roarable Strong Sell) at a spot price of $2.35 (-9.61% 1D, market capitalization $19.0M).
- Fundamental Cash Engine (8/20): Anchored by return on invested capital (ROIC) of -35.0%, gross margin of 62.6%, operating margin of -60.0%, and free cash flow yield of -15.52%.
- Whale 13F & Options Flow (3/20) + Insider Conviction (3/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
- Macro Regime Fit (5/20) + Forensic Balance Sheet (14/20): Incorporates a 1.00x equity beta, Altman Z-Score of 10.69, Piotroski F-Score of 4/9, and Debt/Equity of N/A.
2. Business Model, Unit Margins & SEC Financial Trajectory
ITonic Holdings Ltd (Class A) (ITOC) is a NASDAQ-listed issuer in the Health Care sector, within the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry. Its market capitalization is $0.0B. — The products sold, customer base, and revenue model are not described in the source data.
In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), iTonic Holdings Ltd (Class A) (ITOC) reported $523.0K in annual revenue (up from $448.2K in FY2024, +16.7% YoY) and -$5.1M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($628.6K revenue, -$241.2K net income) through FY2025, ITOC scaled operating cash flow to -$3.2M and free cash flow to -$3.2M, backed by $9.1M in total assets against $0 in total debt.
3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff
- 🐂 Primary Bull Case (E • RQD 33/100): Established market leader in Health Care with deep daily trading liquidity. Free cash flow yield of -15.52% and institutional whale pillar of 3/20. With Fundamental Cash Engine at 8/20 and Institutional Whale Flow at 3/20, sustained execution supports upside toward the upper end of the $2.12 – $18.40 52-week range.
- 🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against -60.0% operating margins and a 1.00x macro beta.
4. 2nd-Order Butterfly Ripples & Key Questions to Watch
Upstream and downstream dependencies, sector correlations, and bottlenecks are — The only sector context provided is the Health Care sector and Electromedical & Electrotherapeutic Apparatus industry classification, which the source does not connect to specific suppliers or customers.
- Key Question #1: Can ITOC sustain or expand its -60.0% operating margin and -35.0% ROIC against Biotechnology: Electromedical & Electrotherapeutic Apparatus peers over the next 4 quarters?
- Key Question #2: Following FY2025 revenue of $523.0K and free cash flow of -$3.2M, how will capital allocation balance growth reinvestment against $0 in total debt?
- Key Question #3: How sensitive is ITOC's equity valuation to Health Care capital spending cycles and macro interest-rate shifts (Beta 1.00x)?
ITOC Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for iTonic Holdings Ltd (Class A) (ITOC) • Click "Debate This Headline" to argue it in the Roar Pit below
🟢 CATALYST Yahoo Finance • 23h ago
iTonic Holdings Ltd Regains Compliance with Nasdaq Minimum Bid Price Requirement Yahoo Finance report covering iTonic Holdings Ltd (Class A) (ITOC) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE TradingView • 1d ago
iTonic Holdings Ltd Estimates – NASDAQ:ITOC TradingView report covering iTonic Holdings Ltd (Class A) (ITOC) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Moomoo • 1d ago
ITonic To Carry Out 1-for-16 Reverse Stock Split On October 6th, 2026 Moomoo report covering iTonic Holdings Ltd (Class A) (ITOC) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Benzinga • 1d ago
12 Health Care Stocks Moving In Monday's After-Market Session - Biomea Fusion (NASDAQ:BMEA), iTonic Holdi Benzinga report covering iTonic Holdings Ltd (Class A) (ITOC) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE kalkine.ca • 1d ago
Why Is iTonic Holdings (NASDAQ:ITOC) Trading Near USD 3.00 After a 7.14% Rebound? kalkine.ca report covering iTonic Holdings Ltd (Class A) (ITOC) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Traders Union • 1d ago
iTonic Holdings Ltd. (ITOC) Stock Price Prediction for 2026, 2030-2040 Traders Union report covering iTonic Holdings Ltd (Class A) (ITOC) market action, institutional positioning, and fundamental catalysts.
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE
3 Active Posts & Replies
ITOC Bull vs. Bear Conversation Board — What's Your Call at $2.35?
🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON ITOC 🐻 33% BEARISH CONVICTION
MA MacroHawk_NYC RQD DEBATE OPENER • Cross-Asset Macro Desk 🐂 BULLISH
🎯 Target: $2.99 (+15.0%)
📌 Pinned Debate The balance sheet is the strongest pillar, with an Altman Z-Score of 10.69 and Debt/Equity of 0.5, and the stock trades near its 52-wee
The balance sheet is the strongest pillar, with an Altman Z-Score of 10.69 and Debt/Equity of 0.5, and the stock trades near its 52-week low.. When you look under the hood at ITOC, Fundamental Cash Engine is 8/20 with 62.6% gross margins and -35.0% ROIC. Bears are staring in the rearview mirror while institutional 13F flow (3/20) has been quietly accumulating below $18.40. My 12M target is $2.99.
VolSurface_Trader 🐂 BULL
Both sides have a point here — ITOC's 14/20 balance sheet score keeps downside contained, so the real swing factor next earnings call is backlog and FCF conversion.
RE RedlineAuditor RQD DEBATE OPENER • Accounting Quality Watch 🐻 BEARISH
🎯 Target: $2.11 (-18.8%)
Spot @ $2.60 Cash fell from $6.2M to $1.5M while FY 2025 operating losses widened to -$5.2M on revenue of $0.5M, with ROIC at -35%.
Here is the bear case nobody on the bull side wants to address on ITOC: Cash fell from $6.2M to $1.5M while FY 2025 operating losses widened to -$5.2M on revenue of $0.5M, with ROIC at -35%.. At current EV/EBITDA multiples, even a small guidance miss in Biotechnology: Electromedical & Electrotherapeutic Apparatus triggers a 12-15% air pocket.